Cargando…
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603000/ https://www.ncbi.nlm.nih.gov/pubmed/34863619 http://dx.doi.org/10.1016/j.vaccine.2021.11.023 |
_version_ | 1784601683347636224 |
---|---|
author | Cambon, L. Schwarzinger, M. Alla, F. |
author_facet | Cambon, L. Schwarzinger, M. Alla, F. |
author_sort | Cambon, L. |
collection | PubMed |
description | France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy. |
format | Online Article Text |
id | pubmed-8603000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86030002021-11-19 Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries Cambon, L. Schwarzinger, M. Alla, F. Vaccine Commentary France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy. Elsevier Ltd. 2022-01-21 2021-11-19 /pmc/articles/PMC8603000/ /pubmed/34863619 http://dx.doi.org/10.1016/j.vaccine.2021.11.023 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Cambon, L. Schwarzinger, M. Alla, F. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries |
title | Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries |
title_full | Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries |
title_fullStr | Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries |
title_full_unstemmed | Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries |
title_short | Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries |
title_sort | increasing acceptance of a vaccination program for coronavirus disease 2019 in france: a challenge for one of the world’s most vaccine-hesitant countries |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603000/ https://www.ncbi.nlm.nih.gov/pubmed/34863619 http://dx.doi.org/10.1016/j.vaccine.2021.11.023 |
work_keys_str_mv | AT cambonl increasingacceptanceofavaccinationprogramforcoronavirusdisease2019infranceachallengeforoneoftheworldsmostvaccinehesitantcountries AT schwarzingerm increasingacceptanceofavaccinationprogramforcoronavirusdisease2019infranceachallengeforoneoftheworldsmostvaccinehesitantcountries AT allaf increasingacceptanceofavaccinationprogramforcoronavirusdisease2019infranceachallengeforoneoftheworldsmostvaccinehesitantcountries |